Press releases
- Press releases
- Browse
Press releases
Sulidin® 1% LPS® Nimesulide gel receives European and US Patents for unique non-alcoholic soluble gel formulation More
HEALTHPOINT Canada, a division of HEALTHPOINT Ltd., , began marketing COOK Biotech Incorporated's patented wound matrix product, Oasis, in Canada this month through a distribution partnership with Trudell Medical Marketing Limited. More
Triseptin® Meets New CDC Guidelines for Surgical Scrubbing More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
ProEthic Laboratories, LLC and Applied Pharma Research have signed a licensing agreement for a once-daily transdermal version of ketoprofen, a member of the NSAID class of drugs that also includes the popular Celebrex and Vioxx brands. More
Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Pharmaceuticals, has filed a US 510k application for CollaGUARD™, an advanced wound care product based on Innocoll's proprietary CollaRx™ membrane technology. More
Patents were recently granted in 12 new countries for SULIDIN® LPS® (Topical Nimesulide Gel). Licensees are sought in these and other territories worldwide. More
Zambon and APR have recently signed a Strategic Alliance and License Agreement for the further development and marketing of innovative patented consumer oriented products in patch form. More
Two new studies on the Efficacy, Tolerability and Safety of Kortos® HC cream and Kortos® HC Suppository have been carried out, found to be highly efficacous and well tolerated with no clinically relevant systemic or local side/adverse effects More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 124 pages - $1,740
Apr 2007 - 118 pages - $2,495
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Dec 2006 - 90 pages - $995
Jun 2009 - 472 pages - $3,140
Jun 2008 - 175 pages - $3,835
Feb 2011 - 23 pages - $350
Mar 2011 - 24 pages - $350
Your selection
Browse By
- Industry sector
- Dermatological
- Oral
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us